Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $5.70 Analyst target: $15.33 Upside: 169.18%
CorMedix Inc., a biopharmaceutical company, focuses on developing and marketing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. The company is headquartered in Berkeley Heights, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.